DK0944611T3 - Dimesylatsalte af neuropeptid Y-ligander - Google Patents

Dimesylatsalte af neuropeptid Y-ligander

Info

Publication number
DK0944611T3
DK0944611T3 DK97910602T DK97910602T DK0944611T3 DK 0944611 T3 DK0944611 T3 DK 0944611T3 DK 97910602 T DK97910602 T DK 97910602T DK 97910602 T DK97910602 T DK 97910602T DK 0944611 T3 DK0944611 T3 DK 0944611T3
Authority
DK
Denmark
Prior art keywords
neuropeptide
ligands
dimesylate
salts
dimesylate salts
Prior art date
Application number
DK97910602T
Other languages
Danish (da)
English (en)
Inventor
Douglas J M Allen
Lyle R Brostrom
Alireza S Kord
Laurie A Whipple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0944611T3 publication Critical patent/DK0944611T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97910602T 1996-11-26 1997-11-19 Dimesylatsalte af neuropeptid Y-ligander DK0944611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en) 1996-11-26 1997-11-19 Dimesylate salts of neuropeptide y ligands

Publications (1)

Publication Number Publication Date
DK0944611T3 true DK0944611T3 (da) 2004-04-13

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97910602T DK0944611T3 (da) 1996-11-26 1997-11-19 Dimesylatsalte af neuropeptid Y-ligander

Country Status (23)

Country Link
US (1) US5914329A (pt)
EP (1) EP0944611B1 (pt)
JP (1) JP3120861B2 (pt)
AP (1) AP9701148A0 (pt)
AR (1) AR010304A1 (pt)
AT (1) ATE257472T1 (pt)
AU (1) AU4792497A (pt)
BR (1) BR9713538A (pt)
CA (1) CA2272927C (pt)
DE (1) DE69727155T2 (pt)
DK (1) DK0944611T3 (pt)
ES (1) ES2213207T3 (pt)
GT (1) GT199700123A (pt)
HN (1) HN1997000154A (pt)
HR (1) HRP970640A2 (pt)
ID (1) ID18964A (pt)
MA (1) MA26450A1 (pt)
PA (1) PA8441701A1 (pt)
PE (1) PE17099A1 (pt)
PT (1) PT944611E (pt)
TN (1) TNSN97191A1 (pt)
WO (1) WO1998023603A1 (pt)
ZA (1) ZA9710587B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
JP2005516001A (ja) 2001-12-05 2005-06-02 ベイラー カレッジ オブ メディスン 交感神経活動状態の調節による骨形成の制御のための方法及び組成物
WO2003057886A2 (en) 2002-01-09 2003-07-17 Arexis Ab Detection of mutations
DK1701722T3 (da) * 2004-11-23 2010-01-11 Dong Wha Pharm Co Ltd N-Hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidin-2-methansulfonsyresalt
AU2006235200A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of Neuropeptide Y (NPY) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL321136A1 (en) * 1994-11-07 1997-11-24 Pfizer Some substituted derivatives of bencylamine as a new class of specific ligands of neuropeptide y1

Also Published As

Publication number Publication date
EP0944611A1 (en) 1999-09-29
GT199700123A (es) 1999-05-19
HN1997000154A (es) 1999-02-09
MA26450A1 (fr) 2004-12-20
HRP970640A2 (en) 1998-10-31
DE69727155T2 (de) 2004-07-08
WO1998023603A1 (en) 1998-06-04
EP0944611B1 (en) 2004-01-07
ID18964A (id) 1998-05-28
PA8441701A1 (es) 2000-05-24
TNSN97191A1 (fr) 2005-03-15
PT944611E (pt) 2004-04-30
AR010304A1 (es) 2000-06-07
JP3120861B2 (ja) 2000-12-25
DE69727155D1 (de) 2004-02-12
CA2272927A1 (en) 1998-06-04
CA2272927C (en) 2003-02-04
JP2000505110A (ja) 2000-04-25
ES2213207T3 (es) 2004-08-16
US5914329A (en) 1999-06-22
AU4792497A (en) 1998-06-22
AP9701148A0 (en) 1998-01-31
BR9713538A (pt) 2000-03-21
ZA9710587B (en) 1999-05-25
ATE257472T1 (de) 2004-01-15
PE17099A1 (es) 1999-02-19

Similar Documents

Publication Publication Date Title
DK1064298T3 (da) Inhibitorer af caspaser
IS4880A (is) Innlyksa kompexar af arýl - heterósýklískum söltum
DK0966430T3 (da) Anti-flammatoriske forbindelser
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
IS2027B (is) Ný spíróasabísýklísk heterósýklísk efnasambönd
ATE261935T1 (de) Neue metformin salze und verfahren
DE60142480D1 (de) Einstellung von aufnahmebedingungen in einer kamera
DE69932378D1 (de) Automatisches Ausrichten von Druckköpfen
FI971635A0 (fi) Menetelmät neuropeptidiin Y liittyvien tilojen inhiboimiseksi
DK0796207T3 (da) Bærer af klemmetypen
DE69724809D1 (de) Refluxinhibitoren
DK144192D0 (da) Aktivering af enzymer
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
DE69811326D1 (de) Chromenverbindungen
DK0695383T3 (da) Efterbehandling af non-woven-duge
DK0745011T3 (da) Dannelse af gevind
DK0944611T3 (da) Dimesylatsalte af neuropeptid Y-ligander
IS5821A (is) Kristalluð form af ósanetant
DK0950051T3 (da) Mikropartikulær form af en tetrahydropyridinforbindelse
DK0883623T3 (da) Fremstilling af chirale titanocener
ATA88199A (de) Schalbauteil
SE9704542D0 (sv) Novel pyridazinone compounds
SE9400968D0 (sv) Heterocyclic compounds
SE9402122D0 (sv) Heterocyclic compounds
DK0815473T3 (da) Bestemmelse af en parameter for en komponent i en sammensætning